Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
James E. Signorovitch
Based on 12 articles published since 2009
(Why 12 articles?)
||||
Expertise Level
The expertise of James E. Signorovitch ranks in the
  • Top 0.81%
  • ... of 37,586 published authors worldwide on Psoriasis
  • ... from 2009 through 2019
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Signorovitch, James   ·   Signorovitch, J E   ·   Signorovitch, J   ·   Signorovitch, James E
Work Locations
Details
Most likely:    Miscellaneous institutions in Boston      
2018
  • Probity Medical Research, and K. Papp Clinical Research, Waterloo, Ontario, Canada. · Analysis Group Inc., Boston, MA, USA. Electronic address: · AbbVie Inc., North Chicago, IL, USA. · Analysis Group Inc., Boston, MA, USA. · Pubmed 29304933
2017
  • Medical College of Wisconsin, Milwaukee, Wisconsin. · Analysis Group Inc, Boston, Massachusetts. Electronic address: · AbbVie Inc, North Chicago, Illinois. · Analysis Group Inc, Boston, Massachusetts. · AbbVie Inc, North Chicago, Illinois; Fort HealthCare, Fort Atkinson, Wisconsin. · Pubmed 28993007
2016
  • Keck School of Medicine, University of Southern California, Los Angeles, California. · Analysis Group Inc, Boston, Massachusetts. Electronic address: · AbbVie, North Chicago, Illinois. · Analysis Group Inc, Boston, Massachusetts. · Pubmed 27476973
  • a Analysis Group, Inc. , Los Angeles , CA , USA ; · b AbbVie Inc. , North Chicago , IL , USA ; · c Analysis Group, Inc. , New York , NY , USA ; · d Analysis Group, Inc. , Boston , MA , USA. · Pubmed 26743448
2015
  • Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, U.S.A. · Pubmed 25288183
2010
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by James E. Signorovitch about Psoriasis:

  • Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials. 2018
  • Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. 2017
  • Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis. 2016
  • An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritis. 2016
  • Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response. 2015
  • Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study. 2014
  • The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. 2012
  • Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials. 2011
  • The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. 2010
  • Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial. 2010
Show List of Full Article Records
Google Searches

Learn more about James E. Signorovitch using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Boston
2018
  • Probity Medical Research, and K. Papp Clinical Research, Waterloo, Ontario, Canada. · Analysis Group Inc., Boston, MA, USA. Electronic address: · AbbVie Inc., North Chicago, IL, USA. · Analysis Group Inc., Boston, MA, USA. · Pubmed 29304933
2017
  • Medical College of Wisconsin, Milwaukee, Wisconsin. · Analysis Group Inc, Boston, Massachusetts. Electronic address: · AbbVie Inc, North Chicago, Illinois. · Analysis Group Inc, Boston, Massachusetts. · AbbVie Inc, North Chicago, Illinois; Fort HealthCare, Fort Atkinson, Wisconsin. · Pubmed 28993007
2016
  • Keck School of Medicine, University of Southern California, Los Angeles, California. · Analysis Group Inc, Boston, Massachusetts. Electronic address: · AbbVie, North Chicago, Illinois. · Analysis Group Inc, Boston, Massachusetts. · Pubmed 27476973
  • a Analysis Group, Inc. , Los Angeles , CA , USA ; · b AbbVie Inc. , North Chicago , IL , USA ; · c Analysis Group, Inc. , New York , NY , USA ; · d Analysis Group, Inc. , Boston , MA , USA. · Pubmed 26743448
2015
  • Analysis Group, Inc., 111 Huntington Avenue, 10th floor, Boston, MA, 02199, U.S.A. · Pubmed 25288183
2010
5 Other Locations Show
Yearly article counts 01121101140
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.